Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.
about
Evolution of management in peritoneal surface malignanciesResection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomesRepeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomesChemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapyMultimodality treatment strategies have changed prognosis of peritoneal metastasesPreoperative selection of patients with colorectal cancer liver metastasis for hepatic resectionRole of multi-modality therapy in peritoneal carcinomatosis and visceral metastasis: a case report and review of the literatureA multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literatureRole of surgery in colorectal cancer liver metastasesTherapeutic options for peritoneal metastasis arising from colorectal cancerPeritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal ChemotherapyMetastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapyEarly results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy.Current treatment options for colon cancer peritoneal carcinomatosis.Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases.Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy onlyDoes hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patientsRepeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study.Metastases of colorectal cancer to the liver and peritoneum: comparison of surgical paradigms."En bloc" caudate lobe and inferior vena cava resection following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal and liver metastasis of colorectal cancer.Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature.Surgical treatment of hepatic metastases from colorectal cancer.Treatment recommendations for metastatic colorectal cancer.Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature.Summary of current therapeutic options for peritoneal metastases from colorectal cancer.Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer.National and international guidelines for rectal cancer.Management of peritoneal carcinomatosis from colorectal cancer: review of the literature.Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.Challenges in the multidisciplinary management of stage IV colon and rectal cancer.Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overviewCytoreductive Surgery and Peritonectomy Procedures.A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC.Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis.Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.Colorectal liver metastases with extrahepatic disease--a new criteria for oncologic resection?Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters.
P2860
Q26741293-2C7C1C05-A273-46A2-B7B5-69A5C65C1B75Q26750691-CCB01FCA-D30D-49DF-B02A-36A721815E03Q26768299-65162523-952F-4DBA-BFC4-2F2FFB0D4A4DQ26768402-7579B864-12B5-4436-B541-E59660B7D399Q26769938-CF0B655F-7858-42B3-93CD-196299C6142EQ26774687-9D2FE02A-A2A2-4026-8F5F-5E441E2D0663Q26799152-8F04F121-8603-426C-B326-E8B8FDF2CDC1Q26800770-3DA781E7-F698-4E64-9875-D6DF444F0228Q26830444-04B53EBB-1601-46F2-9DEA-D04FC4A6BAA2Q28067123-35F11634-6728-46B8-AB42-C1BD3E9DE62FQ31031044-BB07B106-60DB-4B9D-A5C2-E7253F078524Q33850248-25DB8757-3552-4E82-8552-4DC81E0979CBQ34097998-B1CAF79F-C0D7-4DD5-9D6C-7D7D7130F361Q34207816-9C21C9A0-DEA4-4D0C-8103-3585904C7D61Q34326741-59D9E27E-724B-4C85-90A6-C9158CDA5F91Q35234968-0CA10C49-C541-45BF-B6D4-39D46FBB4B1DQ36125424-26F824BE-DE78-49F7-ADFD-FFE022A5A18FQ36611761-C3EF474C-B1D7-45CC-87B5-748085945A40Q36758925-9E0F32DD-E74F-41D7-BDD7-B91A8E1D9F1EQ37285937-2C0D8015-3D44-4D1F-A3F6-CF7A875F38CFQ37316995-497E7302-80AF-4249-8A9E-848788731C74Q37501081-1ACD30C6-2D47-4897-BC64-177BC2C0749DQ37571642-51E8CB31-F405-4BE2-B43C-37415F99127DQ37832394-81FCC74D-D6FA-476A-BB67-4EE42C147498Q37855303-5618CF67-BB3F-47EB-B1A4-3D6E49E1DC75Q38004840-75CDDD25-201D-4D63-BB3B-328EF3F30600Q38017942-C6BFFBD3-D520-4287-AA02-9A09BD3CDA0DQ38183786-C580C222-C240-4F62-8CF0-3A1B9F22B4E1Q38216889-C120AB73-E18D-4BE3-B259-8CFA6D3BE1F1Q38219220-EC476E8D-33AD-4DE8-8910-C279CDCF9A0FQ38244051-627D55C7-25BC-4CA6-B09A-536FE8A9175FQ38246361-FE0E0326-6656-477D-A4D4-D198E609C547Q38260693-3FA915BB-32F3-4C85-8B4C-C5B1C95DF0E8Q38804694-F6598D5A-17F9-43FD-AA0C-633C575068C3Q38836835-FC623B83-C237-42B2-8A03-E8A4AAD8C5C9Q39007389-07A8595A-5284-4D8A-BB42-B31B67771F40Q39014341-C14D6DB0-27A7-4AF6-A6CD-7915648863AAQ39760344-7536E485-8814-4AB8-9BAE-64F92B5585F2Q40343261-84641F88-7CA6-4167-9FF2-5C3B1B85C496Q40764258-1B017CEC-0359-46F8-9C68-337EBA9600A1
P2860
Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Iterative cytoreductive surger ...... h or without liver metastases.
@ast
Iterative cytoreductive surger ...... h or without liver metastases.
@en
Iterative cytoreductive surger ...... h or without liver metastases.
@nl
type
label
Iterative cytoreductive surger ...... h or without liver metastases.
@ast
Iterative cytoreductive surger ...... h or without liver metastases.
@en
Iterative cytoreductive surger ...... h or without liver metastases.
@nl
prefLabel
Iterative cytoreductive surger ...... h or without liver metastases.
@ast
Iterative cytoreductive surger ...... h or without liver metastases.
@en
Iterative cytoreductive surger ...... h or without liver metastases.
@nl
P2093
P2860
P1433
P1476
Iterative cytoreductive surger ...... h or without liver metastases.
@en
P2093
Benjamin Castel
Benoit Coffin
Jean-Marc Sabate
Jean-Marie Hay
Nathalie Pons-Kerjean
Reza Kianmanesh
Simon Msika
Stefano Scaringi
Yves Flamant
P2860
P304
P356
10.1097/01.SLA.0000255561.87771.11
P407
P577
2007-04-01T00:00:00Z